The Full-Length PPTA Donor History Questionnaire and Abbreviated Questionnaire are designed to aid plasma sourcing organizations in evaluating a prospective donor’s history relative to current known safety risks, FDA regulations and recommendations, PPTA voluntary standards, and optionally, European requirements. The Full-Length PPTA DHQ is designed as a stand-alone questionnaire that may be used at each donation. It may also be used in conjunction with an abbreviated form for frequent donors.
The following documents are included as part of the PPTA Donor History Questionnaire:
Version 2.0 (July 2016)
- Full-Length PPTA DHQ
- Full-Length Directions for Use
- Abbreviated DHQ
- Abbreviated Directions for Use
- Medication List
The version 2.0 of the questionnaires and accompanying materials have been recognized by the FDA in a Guidance for Industry as an acceptable mechanism for collecting donor history information from Source Plasma donors. The materials are consistent with FDA's requirements and recommendations for collecting Source Plasma donor history information. For your reference, previous version 1.2 will remain on the website below until we archive later this year.
PPTA Donor History Questionnaire: Version 1.2 (September 2012)
Highlights from IPPC 2017 +
Mr. Bruno Santoni, Executive Director, PPTA Europe, opened the well-attended IPPC 2017 welcoming the more than 300 attendees to Prague. PPTA thanks its sponsors who help make the IPPC possible. Download the IPPC app for a complete list of sessions and many of the presentations.Read More
PPTA Remembers John W. Walsh +
PPTA is Proud to Support Rare Disease Day 2017 +
The Plasma Protein Therapeutics Association (PPTA) is proud to support Rare Disease Day, an annual international event that seeks to raise awareness about rare diseases and the patients and families that are affected by a rare disease.Read More
PPTA Standards Programs